34 Einträge gefunden

1. In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab

   1. Atanackovic, Djordje
   2. Yousef, Sara
   3. Shorter, Christa
   4. Tantravahi, Srinivas K
   5. Steinbach, Mary
   6. Iglesias, Fiorella
   7. Sborov, Douglas

   2020 - Forschungsinformationssystem des UKE
2. B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma

   1. Gagelmann, Nico
   2. Ayuk, Francis
   3. Atanackovic, Djordje
   4. Kröger, Nicolaus

   2020 - Forschungsinformationssystem des UKE
3. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

   1. Sebastian, Martin
   2. Schröder, Andreas
   3. Scheel, Birgit
   4. Hong, Henoch S
   5. Muth, Anke
   6. von Boehmer, Lotta
   7. Zippelius, Alfred

   2019 - Forschungsinformationssystem des UKE
4. A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer

   1. Dizier, Benjamin
   2. Callegaro, Andrea
   3. Debois, Muriel
   4. Dreno, Brigitte
   5. Hersey, Peter
   6. Gogas, Helen J
   7. Kirkwood, John M

   2019 - Forschungsinformationssystem des UKE
5. A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors

   1. Kebenko, Maxim
   2. Goebeler, Marie-Elisabeth
   3. Wolf, Martin
   4. Hasenburg, Annette
   5. Seggewiss-Bernhardt, Ruth
   6. Ritter, Barbara
   7. Rautenberg, Beate

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
6. Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma

   1. Atanackovic, Djordje
   2. Luetkens, Tim
   3. Radhakrishnan, Sabari
   4. Kroger, Nicolaus

   2017 - Forschungsinformationssystem des UKE
7. Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study

   1. Creutzfeldt, Anna
   2. Suling, Anna
   3. Oechsle, Karin
   4. Mehnert, Anja
   5. Atanackovic, Djordje
   6. Kripp, Melanie
   7. Arnold, Dirk

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
8. Characterization of different CTC subpopulations in non-small cell lung cancer

   1. Hanssen, Annkathrin
   2. Wagner, Jenny
   3. Gorges, Tobias M
   4. Tänzer, Aline
   5. Uzunoglu, Faik G
   6. Driemel, Christiane
   7. Stoecklein, Nikolas H

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
9. Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension

   1. Harbaum, Lars
   2. Renk, Emilia
   3. Yousef, Sara
   4. Glatzel, Antonia
   5. Lüneburg, Nicole
   6. Hennigs, Jan K
   7. Oqueka, Tim

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
10. Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer

    1. Stein, Alexander
    2. Atanackovic, Djordje
    3. Hildebrandt, Bert
    4. Stübs, Patrick
    5. Brugger, Wolfram
    6. Hapke, Gunnar
    7. Steffens, Claus-Christoph

    2015 - Forschungsinformationssystem des UKE
11. Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma

    1. Lajmi, Nesrine
    2. Luetkens, Tim
    3. Yousef, Sara
    4. Templin, Julia
    5. Cao, Yanran
    6. Hildebrandt, York
    7. Bartels, Katrin

    2015 - Forschungsinformationssystem des UKE
12. Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma

    1. Yousef, Sara
    2. Heise, Johanna
    3. Lajmi, Nesrine
    4. Bartels, Katrin
    5. Kröger, Nicolaus
    6. Luetkens, Tim
    7. Atanackovic, Djordje

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
13. A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer

    1. Bokemeyer, Carsten
    2. Stein, Alexander
    3. Ridwelski, Karsten
    4. Atanackovic, Djordje
    5. Arnold, Dirk
    6. Wöll, Ewald
    7. Ulrich, Alexis

    2015 - Forschungsinformationssystem des UKE
14. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer

    1. Laban, Simon
    2. Atanackovic, Djordje
    3. Luetkens, Tim
    4. Knecht, Rainald
    5. Busch, Chia-Jung
    6. Freytag, Marcus
    7. Spagnoli, Giulio

    2014 - Forschungsinformationssystem des UKE
15. Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity

    1. Harbaum, Lars
    2. Marx, Andreas
    3. Goekkurt, Eray
    4. Schafhausen, Philippe
    5. Atanackovic, Djordje

    2014 - Forschungsinformationssystem des UKE
16. 5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity

    1. Stübig, Thomas
    2. Badbaran, Anita
    3. Luetkens, Tim
    4. Hildebrandt, York
    5. Atanackovic, Djordje
    6. Binder, Thomas M C
    7. Fehse, Boris

    2014 - Forschungsinformationssystem des UKE - frei zugänglich
17. FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells

    1. Braga, Walter Moises Tobias
    2. da Silva, Bruna Raphaeli
    3. de Carvalho, Ana Carolina
    4. Maekawa, Yumi H
    5. Bortoluzzo, Adriana Bruscato
    6. Rizzatti, Edgar Gil
    7. Atanackovic, Djordje

    2014 - Forschungsinformationssystem des UKE
18. Is there any relationship between gene expression of tumor antigens and CD4+ T cells in multiple myeloma?

    1. Braga, Walter Mt
    2. da Silva, Bruna R
    3. Alves, Veruska Lf
    4. Bortoluzo, Adriana B
    5. Atanackovic, Djordje
    6. Colleoni, Gisele Wb

    2014 - Forschungsinformationssystem des UKE
19. Immune-modulating drugs and hypomethylating agents to prevent or treat relapse after allogeneic stem cell transplantation

    1. Kröger, Nicolaus
    2. Stübig, Thomas
    3. Atanackovic, Djordje

    2014 - Forschungsinformationssystem des UKE
20. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

    1. Wolschke, Christine
    2. Stübig, Thomas
    3. Hegenbart, Ute
    4. Schönland, Stefan
    5. Heinzelmann, Marion
    6. Hildebrandt, York
    7. Ayuketang Ayuk, Francis

    2013 - Forschungsinformationssystem des UKE